1. Biomarkers in MS and NMOSD
  2. Molecular Neuropathology and Neuroimaging
  3. Rehabilitation and Regeneration
  4. Current and Emerging Therapeutic Approaches


Wednesday, 13 November 2019
Main Ballroom
13:30-15:00 European Charcot Foundation Symposium
B Cell Treatment
1. B Cells in MS and NMOSD Evidences from Pathology
2. Are the B Cells the Key Target in Relapsing Multiple Sclerosis
3. Role of B Cells in NMO Spectrum Disorders
4. Anti B Cell Therapies: Now and Tomorrow
15:00-15:30 Coffee Break
15:30-15:45 Opening Ceremony
15:45-17:15 Opening Lecture Series
Opening Lecture-1
L-1 Cellular and molecular mechanisms that orchestrate inflammation during both viral and autoimmune encephalitides via endothelial-immune cell interactions
Opening Lecture-2
L-2 From immuno-ablation to Neuro-repair: have cell-based therapies for MS come of age?
17:15-17:30 Coffee Break & Poster Viewing
17:30-19:00 Sponsored Symposium-1
19:30-21:00 Welcome Reception


Thursday, 14 November 2019
Main Ballroom
08:30-10:00 Sponsored Symposium-2
10:00-10:30 Coffee Break
10:30-11:50 Oral Presentation-1
Clinical Neurology Session
11:50-12:50 Lunch & Poster Viewing
12:50-14:50 Symposium-1
Molecular Neuropathology and Neuroimaging
L-3 Molecular neuropathology of multiple sclerosis
L-4 Glial pathology of MS and NMOSD
L-5 Imaging remyelination in MS: a validated biomarker of lesion repair?
L-6 B cells and regulatory plasma cells in CNS inflammation and autoimmunity
14:50-15:50 Coffee Break & Poster Review
15:50-17:10 Plenary Lectures
Rehabilitation and Regeneration for Demyelinating Diseases
L-12 Rehabilitation of MS: neuroplasticity and neuroregeneration vs compensation and coping
L-13 Repair strategies for progressive MS
17:10-17:30 Coffee Break
17:30-19:00 Sponsored Symposium-3
19:30-23:00 Presidential Dinner


Thursday, 14 November 2019
Breakout Session
12:50-15:20 Symposium-2
Basic Immunology in MS and NMOSD
L-7 T cells in MS
L-8 B cells in MS
L-9 Biomarkers for MS/NMOSD
L-10 Gut immune cells
L-11 Gut microbiome in autoimmune disorders: Insights from the study of NMOSD patients of Indian origin
15:20-15:40 Coffee Break & Poster Review
15:40-17:10 Nursing issues in MS/NMOSD and a patient-support activity session


Friday, 15 November 2019
Main Ballroom
08:30-10:00 Sponsored Symposium-4
10:00-10:30 Coffee Break & Poster Review
10:30-12:30 Symposium-3
Current and emerging therapeutic approaches
L-14 Present and future of B cell targeting therapy
L-15 Immune reconstitution following DMT: the devil is in the detail
L-16 Neuromyelitis optica spectrum disorders: at the vascular-immunology borderlands
L-17 Neuromyelitis optica spectrum disorders: short, medium and long term treatment paradigms
12:30-12:40 Closing and Award Ceremony


Friday, 15 November 2019
Breakout Session
12:50-15:20 Symposium-4
Biomarkers and Diagnosis in MS and NMOSD
L-18 Diagnostic use of metabolomics in multiple sclerosis and its mimics
L-19 The eyes have it: a clinician’s window on inflammatory brain disease
L-20 Lumpers and splitters in NMOSD: does it matter?
L-21 Novel biomarkers for NMO

*subject to change